The metabolism of cyclophosphamide. Dose dependency and the effect of long-term treatment with cyclophosphamide
β Scribed by H. T. Mouridsen; O. Faber; L. Skovsted
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- English
- Weight
- 400 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Seventeen patients less than or equal to 20 years of age with newly diagnosed (n = 10) or recurrent (n = 7) malignant gliomas (anaplastic astrocytoma and glioblastoma multiforme) were treated with cyclophosphamide in association with hematopoietic cytokines (GM-CSF or G-CSF). Cyclophosphamide was gi
## Abstract ## BACKGROUND Decitabine is a hypomethylating agent that has activity in patients with leukemia. The authors combined decitabine with busulfan and cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic stem cell transplantation. ## METHODS Patients with highβris